Filgotinib Demonstrates Durable Efficacy and Consistent Safety Profile at 52 Weeks in FINCH 1 and 3 Studies in Rheumatoid Arthritis
FOSTER CITY, Calif. & MECHELEN, Belgium--(BUSINESS WIRE)--Jun 4, 2020-- |!| Ludington
FOSTER CITY, Calif. & MECHELEN, Belgium--(BUSINESS WIRE)--Jun 4, 2020-- |!| Ludington